| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.100 | None | 0.935 | 62 | 2 | 1992 | 2019 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
disease | 0.100 | None | 0.909 | 33 | 0 | 1999 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.100 | None | 0.920 | 25 | 0 | 1996 | 2018 | ||||||||
|
microRNA 122 | 0.468 | 0.808 |
|
disease | 0.100 | None | 1.000 | 18 | 0 | 2006 | 2020 | |||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
disease | 0.100 | None | 1.000 | 16 | 0 | 2012 | 2019 | ||||||||
|
alpha fetoprotein | 0.429 | 0.885 | 1.1E-11 |
|
disease | 0.100 | None | 1.000 | 13 | 0 | 1985 | 2019 | ||||||||
|
peroxisome proliferator activated receptor alpha | 0.432 | 0.885 | 3.0E-02 |
|
disease | 0.100 | None | 1.000 | 12 | 0 | 2000 | 2018 | ||||||||
|
nuclear factor, erythroid 2 like 2 | 0.357 | 0.885 | 3.6E-03 |
|
disease | 0.100 | None | 1.000 | 11 | 0 | 2007 | 2020 | ||||||||
|
H3 histone pseudogene 10 | 0.350 | 0.846 |
|
disease | 0.100 | None | 1.000 | 10 | 0 | 1996 | 2015 | |||||||||
|
androgen receptor | 0.351 | 0.846 | 0.99 |
|
disease | 0.100 | None | 0.900 | 10 | 0 | 2002 | 2018 | ||||||||
|
transforming growth factor alpha | 0.432 | 0.885 | 0.72 |
|
disease | 0.100 | None | 0.900 | 10 | 0 | 1992 | 2015 | ||||||||
|
fibroblast growth factor 19 | 0.548 | 0.615 | 0.57 |
|
disease | 0.080 | None | 0.750 | 8 | 0 | 2008 | 2019 | ||||||||
|
GA binding protein transcription factor subunit alpha | 0.379 | 0.885 | 1.00 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 2007 | 2020 | ||||||||
|
insulin like growth factor 2 | 0.390 | 0.885 | 4.4E-02 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 1988 | 2019 | ||||||||
|
hepatocyte growth factor | 0.374 | 0.885 | 1.00 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 1994 | 2019 | ||||||||
|
glutathione S-transferase kappa 1 | 0.412 | 0.885 | 1.9E-06 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 1996 | 2017 | ||||||||
|
solute carrier organic anion transporter family member 6A1 | 0.412 | 0.885 | 2.9E-11 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 1996 | 2017 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
disease | 0.070 | None | 0.857 | 7 | 0 | 1999 | 2015 | ||||||||
|
DLC1 Rho GTPase activating protein | 0.529 | 0.731 | 1.00 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2000 | 2013 | ||||||||
|
insulin like growth factor 1 | 0.318 | 0.885 | 0.27 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 1995 | 2018 | ||||||||
|
proteasome 26S subunit, non-ATPase 10 | 0.552 | 0.808 | 0.50 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2008 | 2019 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
disease | 0.070 | None | 0.857 | 7 | 0 | 2002 | 2014 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
disease | 0.070 | None | 0.857 | 7 | 0 | 1985 | 2015 | ||||||||
|
cytochrome P450 family 2 subfamily E member 1 | 0.459 | 0.885 | 8.1E-09 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 1995 | 2018 | ||||||||
|
TERT 5' regulatory region | 0.464 | 0.731 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2014 | 2019 |